Skip to main content

A MULTICENTER, RANDOMIZED, INVESTIGATOR- AND SUBJECT-BLIND, PLACEBO-CONTROLLED, TREATMENT SEQUENCE STUDY EVALUATING THE SAFETY, TOLERABILITY, AND EFFICACY OF UCB7665 IN SUBJECTS WITH MODERATE TO SEVERE MYASTHENIA GRAVIS

Clinical Trial Grant
Duke Scholars

Administered By

Neurology, Neuromuscular Disease

Awarded By

UCB Biosciences Inc.

Start Date

June 19, 2017

End Date

July 31, 2020
 

Administered By

Neurology, Neuromuscular Disease

Awarded By

UCB Biosciences Inc.

Start Date

June 19, 2017

End Date

July 31, 2020